4.7 Article

First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 52, Issue 9, Pages 3085-3091

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01585-07

Keywords

-

Funding

  1. HKSAR University Grants Committee Areas of Excellence Fund [AoE P/10]
  2. University Grants Council [HKUST 6091/02P, HKUST 6493/06 M]
  3. Medicines for Malaria Ventures, Geneva, Switzerland

Ask authors/readers for more resources

In preclinical studies, artemisone (BAY 44-9585), a new artemisinin derivative, was shown to possess enhanced efficacy over artesunate, and it does not possess the neurotoxicity characteristic of the current artemisinins. In a phase I program with double-blind, randomized, placebo-controlled, single and multiple ascending oral-dose studies, we evaluated the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of artemisone. Single doses (10, 20, 30, 40, and 80 mg) and multiple doses (40 and 80 mg daily for 3 days) of artemisone were administered orally to healthy subjects. Plasma concentrations of artemisone and its metabolites were measured by liquid chromatography/ tandem mass spectrometry (LC/MS-MS). Artemisone was well tolerated, with no serious adverse events and no clinically relevant changes in laboratory and vital parameters. The pharmacokinetics of artemisone over the 10- to 80-mg range demonstrated dose linearity. After the single 80-mg dose, artemisone had a geometric mean maximum concentration of 140.2 ng/ml (range, 86.6 to 391.0), a short elimination half-life (t(1/2)) of 2.79 h (range, 1.56 to 4.88), a high oral clearance of 284.1 liters/h (range, 106.7 to 546.7), and a large volume of distribution of 14.50 liters/kg (range, 3.21 to 51.58). Due to artemisone's short t(1/2), its pharmacokinetics were comparable after single and multiple dosing. Plasma samples taken after multiple dosing showed marked ex vivo pharmacodynamic antimalarial activities against two multidrug-resistant Plasmodium falciparum lines. Artemisone equivalent concentrations measured by bioassay revealed higher activity than artemisone measured by LC/MS-MS, confirming the presence of active metabolites. Comparable to those of other artemisinin's, artemisone's t(1/2) is well suited for artemisinin-based combination therapy for the treatment of P. falciparum malaria.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Varying degrees of homostructurality in a series of cocrystals of antimalarial drug 11-azaartemisinin with salicylic acids

Monalisa Roy, Keyao Li, Madiha Nisar, Lawrence W-Y Wong, Herman H-Y Sung, Richard K. Haynes, Ian D. Williams

Summary: The X-ray structures of three new 1:1 pharmaceutical cocrystals of 11-aza-artemisinin with bromo-substituted salicylic acids are reported, showing variations in their packing arrangements. This study provides insight into the crystal packing efficiency of the cocrystals based on hydrogen bonding interactions.

ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2021)

Article Microbiology

Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether

Daniel J. Watson, Lizahn Laing, Liezl Gibhard, Ho Ning Wong, Richard K. Haynes, Lubbe Wiesner

Summary: The article reviews the pharmacokinetic properties of various amino-artemisinins in mice, highlighting their potential as components of triple combination therapies due to favorable efficacy and pharmacokinetics.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Microbiology

In Vitro Activity of the Arylaminoartemisinin GC012 against Helicobacter pylori and Its Effects on Biofilm

Francesca Sisto, Simone Carradori, Sarah D'Alessandro, Nadia Santo, Norma Lattuada, Richard K. Haynes, Donatella Taramelli, Rossella Grande

Summary: This study evaluated the in vitro activity of arylaminoartemisinin GC012 against clinical strains of H. pylori with different antibiotic susceptibilities. GC012 showed significantly lower MIC and MBC values compared to DHA, indicating its potential as an effective treatment for H. pylori infection. Combination of GC012 with metronidazole, clarithromycin, and amoxicillin displayed synergistic interactions. Additionally, GC012 inhibited biofilm formation and showed minimal biofilm eradication concentration (MBEC) on mature biofilm. Structural changes in the bacterial membrane were observed for both GC012 and DHA.

PATHOGENS (2022)

Review Infectious Diseases

Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems

Danielle van Staden, Richard K. Haynes, Joe M. Viljoen

Summary: Despite available chemotherapeutic treatment regimens and efforts to develop new drugs for tuberculosis, the disease remains challenging to treat due to the nature of the causative pathogen and drug resistance. The World Health Organization introduced the End-TB initiative to eliminate tuberculosis, but the COVID-19 pandemic has hindered progress. Therefore, there is a need for enhanced scientific understanding, repurposing of drugs, and new treatment methods. This review focuses on utilizing self-double-emulsifying drug delivery systems for topical treatment of cutaneous tuberculosis and other mycobacterial infections.

ANTIBIOTICS-BASEL (2022)

Article Pharmacology & Pharmacy

The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria

Daniel J. J. Watson, Lizahn Laing, Richard M. M. Beteck, Liezl Gibhard, Richard K. K. Haynes, Lubbe Wiesner

Summary: The emergence of drug-resistant malaria strains has necessitated the development of new combination therapies. In this study, the pharmacokinetics of decoquinate and its derivatives were analyzed, revealing promising activity and ease of preparation.

FRONTIERS IN PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

Antimalarial and antitumour activities of the steroidal quinone-methide celastrol and its combinations with artemiside, artemisone and methylene blue

Jerome P. L. Ng, Yu Han, Li Jun Yang, Lyn-Marie Birkholtz, Dina Coertzen, Ho Ning Wong, Richard K. Haynes, Paolo Coghi, Vincent Kam Wai Wong

Summary: Artemisinin, a compound derived from the traditional Chinese medicinal plant Artemisia annua, is commonly used for malaria treatment. However, the emergence of drug resistance has prompted the search for new drug combinations. This study found that the triterpenoid quinone methide celastrol, isolated from the traditional Chinese medicinal plant Tripterygium wilfordii, displayed good antimalarial activity in combination with amino-artemisinins. Celastrol also showed synergistic effects against liver cancer cells. However, further modifications are needed to mitigate its toxicity.

FRONTIERS IN PHARMACOLOGY (2022)

Article Crystallography

Control of 11-Aza:4-X-SalA Cocrystal Polymorphs Using Heteroseeds That Switch On/Off Halogen Bonding

Keyao Li, Monalisa Roy, Madiha Nisar, Lawrence W-Y Wong, Herman H-Y Sung, Richard K. Haynes, Ian D. Williams

Summary: This study demonstrates the formation of different types of cocrystals using different seeds, while also showing the role of halogen bonds in discriminating between different polymorphic types.

CRYSTALS (2022)

Article Pharmacology & Pharmacy

Assessment of Thermal and Hydrolytic Stabilities and Aqueous Solubility of Artesunate for Formulation Studies

J. W. Bezuidenhout, M. Aucamp, N. Stieger, W. Liebenberg, R. K. Haynes

Summary: To establish the best processing parameters and storage conditions for nanolipid formulations of artesunate, the thermal stability and solubility profiles of artesunate in aqueous solutions were evaluated at different temperatures and pH levels. The study found that artesunate remained relatively stable at temperatures up to 40°C and 75% relative humidity for 3 months, with approximately 9% decomposition. However, higher temperatures led to significantly greater decomposition and the formation of dihydroartemisinin (DHA) and other products. The solubility of artesunate varied with pH, with the highest solubility observed at pH 6.8 (phosphate buffer). Overall, maintaining relatively low temperatures is crucial for the preparation and storage of artesunate formulations.

AAPS PHARMSCITECH (2023)

Article Biochemistry & Molecular Biology

Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2: A repurposing study

Giovanni Ribaudo, Xiaoyun Yun, Alberto Ongaro, Erika Oselladore, Jerome P. L. Ng, Richard K. Haynes, Betty Yuen Kwan Law, Maurizio Memo, Vincent Kam Wai Wong, Paolo Coghi, Alessandra Gianoncelli

Summary: By utilizing computational tools, this study identified two potential antimalarial drugs, amodiaquine and methylene blue, as possible PLpro inhibitors. These findings provide a starting point for the development of new PLpro inhibitors.

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Review Plant Sciences

Discovery of artemisinin in Artemisia annua, its current production, and relevance to sub-Saharan Africa

Barend Jacobus Lee, Morne Weyers, Richard Kingston Haynes, Frank van der Kooy

Summary: This article reviews the history of the discovery of artemisinin and the development of combination therapies, as well as the current production techniques and the possibility of producing artemisinin in South Africa. Although artemisinin and its derivatives are widely used for malaria treatment worldwide, the supply is insufficient, especially when used for other diseases. To meet the demand, higher yielding cultivars and novel extraction and purification techniques are needed.

SOUTH AFRICAN JOURNAL OF BOTANY (2023)

Article Parasitology

Proteomic characterization of Toxoplasma gondii ME49 derived strains resistant to the artemisinin derivatives artemiside and artemisone implies potential mode of action independent of ROS formation

Joachim Mueller, Carling Schlange, Manfred Heller, Anne-Christine Uldry, Sophie Braga-Lagache, Richard K. Haynes, Andrew Hemphill

Summary: Artemisinin and its amino-artemisinin derivatives are potent antimalarials and exhibit different mechanisms of action against Plasmodium and T. gondii. The amino-artemisinins are effective in vitro against non-heme-degrading apicomplexan parasites including T. gondii. However, T. gondii strains readily adapt to increased concentrations of these compounds, resulting in the development of resistant strains.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2023)

Review Pharmacology & Pharmacy

The Science of Selecting Excipients for Dermal Self-Emulsifying Drug Delivery Systems

Danielle van Staden, Richard K. K. Haynes, Joe M. M. Viljoen

Summary: Self-emulsification is a formulation technique that improves oral drug delivery by enhancing solubility and bioavailability. It provides a simplified method for delivering lipophilic drugs by producing emulsions upon moderate agitation and dilution. It is also a promising approach for topical drug delivery, offering simplified production procedures and unlimited upscaling possibilities.

PHARMACEUTICS (2023)

Article Microbiology

In Vitro versus in Mice: Efficacy and Safety of Decoquinate and Quinoline-O-Carbamate Derivatives against Experimental Infection with Neospora caninum Tachyzoites

Jessica Ramseier, Dennis Imhof, Kai Pascal Alexander Haenggeli, Nicoleta Anghel, Ghalia Boubaker, Richard M. Beteck, Luis-Miguel Ortega-Mora, Richard K. K. Haynes, Andrew Hemphill

Summary: The effects of decoquinate and three O-quinoline-carbamate-derivatives were investigated on human foreskin fibroblasts infected with Neospora caninum tachyzoites. These compounds exhibited different levels of proliferation inhibition and did not affect cell viability at certain concentrations. Treatment with lower concentrations altered the ultrastructure of the parasite, while long-term treatment with one compound showed parasiticidal effects. These compounds were then tested in a murine model, but did not show activity against neosporosis.

PATHOGENS (2023)

Article Chemistry, Medicinal

The Development of Dermal Self-Double-Emulsifying Drug Delivery Systems: Preformulation Studies as the Keys to Success

Danielle van Staden, Richard K. Haynes, Joe M. Viljoen

Summary: Self-emulsifying drug delivery systems (SEDDSs) are lipid-based systems that provide superior drug protection and control over drug concentration profiles, making them a promising option for oral drug delivery. Dermal spontaneous emulsions have also gained interest due to their ability to deliver drugs across mucus membranes and skin layers.

PHARMACEUTICALS (2023)

Review Chemistry, Medicinal

Artemisia Species and Their Active Constituents for Treating Schistosomiasis

Lorencia Taljaard, Richard K. Haynes, Frank van der Kooy

Summary: Schistosomiasis, a neglected tropical disease, can be controlled and ultimately eliminated by reducing snail populations and preventing and treating schistosomiasis infections. Novel antischistosomal drugs are needed to address concerns about drug resistance, and the genus Artemisia shows promise due to its effects on both schistosomes and snail vectors. The combination of artemisinin and praziquantel presents a potential treatment option for schistosomiasis.

REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY (2023)

No Data Available